e-Therapeutics plc (ETX) Ordinary 0.1p

- Add to watchlist
- Create an alert
- This stock can be held in a




20.18p
21.12p
22.75p
£84.89 million
20.18p
20.00p
3.45p
n/a
0.18p (0.86%) Previous:
0.18p
289,350
n/a
15,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/01/2020 | 31/01/2019 |
---|---|---|
Revenue (£m) | 0.46 | 0.04 |
Profit before tax (£m) | (2.87) | (5.08) |
Adjusted EPS (p): | (0.87) | (1.49) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
e-Therapeutics 're-energised' by Mortazavi appointment
12 October 2020 10:06
-
E-therapeutics enters collaboration deal with Galapagos
10 June 2020 09:20
-
E-therapeutics to collaborate with unnamed pharma giant
13 August 2019 10:35
-
Holding(s) in Company
12 January 2021 11:24
-
Director/PDMR Shareholding
4 January 2021 16:31
-
Holding(s) in Company
18 December 2020 17:44
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.